{"count": 21, "results": [{"_id": "6749509", "pmid": 6749509, "title": "Clinical pharmacokinetics of atenolol--a review.", "journal": "Eur J Drug Metab Pharmacokinet", "authors": ["Kirch W", "Görg KG"], "date": "1982-01-01T00:00:00Z", "doi": "10.1007/BF03188723", "meta_date_publication": "1982", "meta_volume": "7", "meta_issue": "2", "meta_pages": "81-91", "score": 50068.164, "text_hl": "In @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@impaired renal function@@@ elimination half life of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ gradually increases to values of 36 h in @DISEASE_Hemolytic_Uremic_Syndrome @DISEASE_MESH:D006463 @@@uraemic@@@ @SPECIES_9606 @@@patients@@@ (glomerular filtration rate (GFR) less than 10 ml/min). ", "citations": {"NLM": "Kirch W, Görg KG. Clinical pharmacokinetics of atenolol--a review. Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91. PMID: 6749509", "BibTeX": "@article{6749509, title={Clinical pharmacokinetics of atenolol--a review.}, author={Kirch W and Görg KG}, journal={Eur J Drug Metab Pharmacokinet}, volume={7}, number={2}, pages={81-91}}"}}, {"_id": "6933939", "pmid": 6933939, "title": "Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis.", "journal": "Arch Toxicol Suppl", "authors": ["Kirch W", "Schäfer M", "Braun M"], "date": "1980-01-01T00:00:00Z", "doi": "10.1007/978-3-642-67729-8_79", "meta_date_publication": "1980", "meta_volume": "4", "meta_issue": "", "meta_pages": "366-9", "score": 50066.41, "text_hl": "Single intravenous dose kinetics accumulation of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@impaired renal function@@@ and on hemodialysis.", "citations": {"NLM": "Kirch W, Schäfer M, Braun M. Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis. Arch Toxicol Suppl. 1980;4():366-9. PMID: 6933939", "BibTeX": "@article{6933939, title={Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis.}, author={Kirch W and Schäfer M and Braun M}, journal={Arch Toxicol Suppl}, volume={4}, pages={366-9}}"}}, {"_id": "23347063", "pmid": 23347063, "title": "Case report: atenolol overdose successfully treated with hemodialysis.", "journal": "Hemodial Int", "authors": ["Huang SH", "Tirona RG", "Ross C", "Suri RS"], "date": "2013-10-01T00:00:00Z", "doi": "10.1111/hdi.12020", "meta_date_publication": "2013 Oct", "meta_volume": "17", "meta_issue": "4", "meta_pages": "652-5", "score": 50064.7, "text_hl": "Hemodialysis therapy is an effective treatment for @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@, especially in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@impaired renal function@@@. ", "citations": {"NLM": "Huang SH, Tirona RG, Ross C, Suri RS. Case report: atenolol overdose successfully treated with hemodialysis. Hemodial Int. 2013 Oct;17(4):652-5. PMID: 23347063", "BibTeX": "@article{23347063, title={Case report: atenolol overdose successfully treated with hemodialysis.}, author={Huang SH and Tirona RG and Ross C and Suri RS}, journal={Hemodial Int}, volume={17}, number={4}, pages={652-5}}"}}, {"_id": "8914031", "pmid": 8914031, "title": "Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.", "journal": "Kidney Int", "authors": ["Bakris GL", "Copley JB", "Vicknair N", "Sadler R", "Leurgans S"], "date": "1996-11-01T00:00:00Z", "doi": "10.1038/ki.1996.480", "meta_date_publication": "1996 Nov", "meta_volume": "50", "meta_issue": "5", "meta_pages": "1641-50", "score": 50057.977, "text_hl": "Moreover, this enhanced slowing of @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal disease@@@ progression correlated with sustained and significant reductions in @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@, findings not observed in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group.", "citations": {"NLM": "Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int. 1996 Nov;50(5):1641-50. PMID: 8914031", "BibTeX": "@article{8914031, title={Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.}, author={Bakris GL and Copley JB and Vicknair N and Sadler R and Leurgans S}, journal={Kidney Int}, volume={50}, number={5}, pages={1641-50}}"}}, {"_id": "15071353", "pmid": 15071353, "title": "Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats.", "journal": "J Cardiovasc Pharmacol", "authors": ["Zhang C", "Xie HH", "Lu ZA", "Zhu MJ", "Su DF"], "date": "2004-05-01T00:00:00Z", "doi": "10.1097/00005344-200405000-00008", "meta_date_publication": "2004 May", "meta_volume": "43", "meta_issue": "5", "meta_pages": "663-8", "score": 50057.773, "text_hl": "Long-term treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ significantly prevented the @DISEASE_Organizing_Pneumonia @DISEASE_MESH:D000092124 @@@organ damage@@@ with a decrease in left ventricular weight, cardiac and aortic collagen contents, and @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@glomerular injury@@@ score in SAD @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Zhang C, Xie HH, Lu ZA, Zhu MJ, Su DF. Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats. J Cardiovasc Pharmacol. 2004 May;43(5):663-8. PMID: 15071353", "BibTeX": "@article{15071353, title={Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats.}, author={Zhang C and Xie HH and Lu ZA and Zhu MJ and Su DF}, journal={J Cardiovasc Pharmacol}, volume={43}, number={5}, pages={663-8}}"}}, {"_id": "3889077", "pmid": 3889077, "title": "Effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients.", "journal": "J Clin Pharmacol", "authors": ["Koh H", "Nambu S", "Ikeda M"], "date": "1985-04-01T00:00:00Z", "doi": "10.1002/j.1552-4604.1985.tb02830.x", "meta_date_publication": "1985 Apr", "meta_volume": "25", "meta_issue": "3", "meta_pages": "230-2", "score": 50056.96, "text_hl": "The results suggest that @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ provides a favorable effect on renal function in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive diabetic@@@ @SPECIES_9606 @@@patients@@@ uncomplicated by @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@renal dysfunction@@@.", "citations": {"NLM": "Koh H, Nambu S, Ikeda M. Effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients. J Clin Pharmacol. 1985 Apr;25(3):230-2. PMID: 3889077", "BibTeX": "@article{3889077, title={Effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients.}, author={Koh H and Nambu S and Ikeda M}, journal={J Clin Pharmacol}, volume={25}, number={3}, pages={230-2}}"}}, {"_id": "8331202", "pmid": 8331202, "title": "Impaired elimination of atenolol in a nephropathic patient with self-medication overdose.", "journal": "J Clin Pharmacol", "authors": ["el-Yazigi A", "Bouchama A", "al-Abdely H", "Yusuf A", "Sieck JO"], "date": "1993-05-01T00:00:00Z", "doi": "10.1002/j.1552-4604.1993.tb04686.x", "meta_date_publication": "1993 May", "meta_volume": "33", "meta_issue": "5", "meta_pages": "450-2", "score": 50056.074, "text_hl": "A case of intoxication with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (plasma concentration of 2.71 mg/L) caused by an improper self-medication combined with @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@impaired renal function@@@ is presented. ", "citations": {"NLM": "el-Yazigi A, Bouchama A, al-Abdely H, Yusuf A, Sieck JO. Impaired elimination of atenolol in a nephropathic patient with self-medication overdose. J Clin Pharmacol. 1993 May;33(5):450-2. PMID: 8331202", "BibTeX": "@article{8331202, title={Impaired elimination of atenolol in a nephropathic patient with self-medication overdose.}, author={el-Yazigi A and Bouchama A and al-Abdely H and Yusuf A and Sieck JO}, journal={J Clin Pharmacol}, volume={33}, number={5}, pages={450-2}}"}}, {"_id": "17984671", "pmid": 17984671, "title": "Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.", "journal": "J Hypertens", "authors": ["Pires MJ", "Rodríguez-Peña AB", "Arévalo M", "Cenador B", "Evangelista S", "Esteller A", "Sánchez-Rodríguez A", "Colaço A", "López-Novoa JM"], "date": "2007-12-01T00:00:00Z", "doi": "10.1097/HJH.0b013e3282efeecb", "meta_date_publication": "2007 Dec", "meta_volume": "25", "meta_issue": "12", "meta_pages": "2486-96", "score": 50055.992, "text_hl": "One week after ablation, @SPECIES_10116 @@@rats@@@ were distributed randomly according to the following experimental groups: control group containing @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@RMR@@@ @SPECIES_10116 @@@rats@@@ without treatment; @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@RMR@@@ @SPECIES_10116 @@@rats@@@ treated daily with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ for 6 months (drinking water, 8 mg/kg per day); and @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@RMR@@@ @SPECIES_10116 @@@rats@@@ treated daily with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for 6 months (drinking water, 80 mg/kg per day). ", "citations": {"NLM": "Pires MJ, Rodríguez-Peña AB, Arévalo M, Cenador B, Evangelista S, Esteller A, Sánchez-Rodríguez A, Colaço A, López-Novoa JM. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction. J Hypertens. 2007 Dec;25(12):2486-96. PMID: 17984671", "BibTeX": "@article{17984671, title={Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.}, author={Pires MJ and Rodríguez-Peña AB and Arévalo M and Cenador B and Evangelista S and Esteller A and Sánchez-Rodríguez A and Colaço A and López-Novoa JM}, journal={J Hypertens}, volume={25}, number={12}, pages={2486-96}}"}}, {"_id": "22089474", "pmid": 22089474, "title": "Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).", "journal": "Ther Adv Cardiovasc Dis", "authors": ["Igase M", "Yokoyama H", "Ferrario CM"], "date": "2011-12-01T00:00:00Z", "doi": "10.1177/1753944711429343", "meta_date_publication": "2011 Dec", "meta_volume": "5", "meta_issue": "6", "meta_pages": "297-304", "score": 50053.113, "text_hl": "The @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@glomerular sclerosis@@@ (@<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@GS@@@) index was lowered by @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ compared with the vehicle group. ", "citations": {"NLM": "Igase M, Yokoyama H, Ferrario CM. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7). Ther Adv Cardiovasc Dis. 2011 Dec;5(6):297-304. PMID: 22089474", "BibTeX": "@article{22089474, title={Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).}, author={Igase M and Yokoyama H and Ferrario CM}, journal={Ther Adv Cardiovasc Dis}, volume={5}, number={6}, pages={297-304}}"}}, {"_id": "38096", "pmid": 38096, "title": "Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.", "journal": "Drugs", "authors": ["Heel RC", "Brogden RN", "Speight TM", "Avery GS"], "date": "1979-06-01T00:00:00Z", "doi": "10.2165/00003495-197917060-00001", "meta_date_publication": "1979 Jun", "meta_volume": "17", "meta_issue": "6", "meta_pages": "425-60", "score": 50052.277, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ is eliminated virtually entirely as unchanged drug in the urine and dosage needs to be reduced in @SPECIES_9606 @@@patients@@@ with moderate to severely @<m>DISEASE_Kidney_Diseases</m> @DISEASE_MESH:D007674 @@@impaired renal function@@@ (glomerular filtration rate less than 30 ml/min). ", "citations": {"NLM": "Heel RC, Brogden RN, Speight TM, Avery GS. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. Drugs. 1979 Jun;17(6):425-60. PMID: 38096", "BibTeX": "@article{38096, title={Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.}, author={Heel RC and Brogden RN and Speight TM and Avery GS}, journal={Drugs}, volume={17}, number={6}, pages={425-60}}"}}]}